(September 16, 2015, 10:44 AM EDT) -- DEERFIELD, Ill. — Takeda Pharmaceutical Co. Ltd. on Sept. 12 announced that more than 96 percent of eligible claimants have opted in to the $2.4 billion Actos bladder cancer settlement, triggering a $2.37 billion payment by the company into a settlement fund....